Found: 113
Select item for more details and to access through your institution.
Lifestyle and Parkinson's disease progression.
- Published in:
- 2019
- By:
- Publication type:
- editorial
Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dietary antioxidants and Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- editorial
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intake of antioxidant vitamins and risk of Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Caffeine consumption and risk of dyskinesia in CALM-PD.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Caffeine consumption and risk of dyskinesia in CALM- PD.
- Published in:
- Movement Disorders, 2013, v. 28, n. 3, p. 380, doi. 10.1002/mds.25319
- By:
- Publication type:
- Article
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.
- Published in:
- Movement Disorders, 2012, v. 27, n. 11, p. 1392, doi. 10.1002/mds.25157
- By:
- Publication type:
- Article
Caffeine and risk of Parkinson's disease in a large cohort of men and women.
- Published in:
- Movement Disorders, 2012, v. 27, n. 10, p. 1276, doi. 10.1002/mds.25076
- By:
- Publication type:
- Article
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women.
- Published in:
- Movement Disorders, 2012, v. 27, n. 8, p. 980, doi. 10.1002/mds.25050
- By:
- Publication type:
- Article
Obesity, diabetes, and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2011, v. 26, n. 12, p. 2253, doi. 10.1002/mds.23855
- By:
- Publication type:
- Article
Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study.
- Published in:
- Movement Disorders, 2011, v. 26, n. 12, p. 2283, doi. 10.1002/mds.23934
- By:
- Publication type:
- Article
Serum urate and probability of dopaminergic deficit in early 'Parkinson's disease'.
- Published in:
- Movement Disorders, 2011, v. 26, n. 10, p. 1864, doi. 10.1002/mds.23741
- By:
- Publication type:
- Article
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease".
- Published in:
- 2011
- By:
- Publication type:
- journal article
Restless legs syndrome and Parkinson's disease in men.
- Published in:
- Movement Disorders, 2010, v. 25, n. 15, p. 2654, doi. 10.1002/mds.23256
- By:
- Publication type:
- Article
Calcium channel blocker use and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 12, p. 1818, doi. 10.1002/mds.23191
- By:
- Publication type:
- Article
Prenatal and early life factors and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2010, v. 25, n. 11, p. 1560, doi. 10.1002/mds.23339
- By:
- Publication type:
- Article
Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 9, p. 1359, doi. 10.1002/mds.22619
- By:
- Publication type:
- Article
Perceived imbalance and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 4, p. 613, doi. 10.1002/mds.21919
- By:
- Publication type:
- Article
Telomere length and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 2, p. 302, doi. 10.1002/mds.21867
- By:
- Publication type:
- Article
Recreational physical activity and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2008, v. 23, n. 1, p. 69, doi. 10.1002/mds.21772
- By:
- Publication type:
- Article
Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.
- Published in:
- Movement Disorders, 2006, v. 21, n. 7, p. 1002, doi. 10.1002/mds.20881
- By:
- Publication type:
- Article
Prospective study of phobic anxiety and risk of Parkinson's disease.
- Published in:
- Movement Disorders, 2003, v. 18, n. 6, p. 646, doi. 10.1002/mds.10425
- By:
- Publication type:
- Article
Protection of dopaminergic cells by urate requires its accumulation in astrocytes.
- Published in:
- Journal of Neurochemistry, 2012, v. 123, n. 1, p. 172, doi. 10.1111/j.1471-4159.2012.07820.x
- By:
- Publication type:
- Article
Inactivation of neuronal forebrain A<sub>2A</sub> receptors protects dopaminergic neurons in a mouse model of Parkinson’s disease.
- Published in:
- Journal of Neurochemistry, 2009, v. 111, n. 6, p. 1478, doi. 10.1111/j.1471-4159.2009.06425.x
- By:
- Publication type:
- Article
Adenosine A<sub>2A</sub> receptor stimulation potentiates nitric oxide release by activated microglia.
- Published in:
- Journal of Neurochemistry, 2005, v. 95, n. 4, p. 919, doi. 10.1111/j.1471-4159.2005.03395.x
- By:
- Publication type:
- Article
Particulate matter and risk of Parkinson disease in a large prospective study of women.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson's Disease Clinical Trial: A Pilot Study.
- Published in:
- Digital Biomarkers, 2022, v. 6, n. 1, p. 1, doi. 10.1159/000521232
- By:
- Publication type:
- Article
A Crucial Role for Forebrain Adenosine A<sub>2A</sub> Receptors in Amphetamine Sensitization.
- Published in:
- Neuropsychopharmacology, 2005, v. 30, n. 5, p. 891, doi. 10.1038/sj.npp.1300630
- By:
- Publication type:
- Article
Inactivation of Adenosine A<sub>2A</sub> Receptors Selectively Attenuates Amphetamine-Induced Behavioral Sensitization.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 6, p. 1086, doi. 10.1038/sj.npp.1300152
- By:
- Publication type:
- Article
Adenosine A2A Receptor Antagonists for Parkinson’s Disease: Rationale, Therapeutic Potential and Clinical Experience.
- Published in:
- Drugs & Aging, 2005, v. 22, n. 6, p. 471, doi. 10.2165/00002512-200522060-00002
- By:
- Publication type:
- Article
Long-Term Use of Antibiotics and Risk of Parkinson's Disease in the Nurses' Health Study.
- Published in:
- Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/4038375
- By:
- Publication type:
- Article
Urate in Parkinson's Disease: More Than a Biomarker?
- Published in:
- Current Neurology & Neuroscience Reports, 2012, v. 12, n. 4, p. 367, doi. 10.1007/s11910-012-0282-7
- By:
- Publication type:
- Article
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 8, p. 2668, doi. 10.1093/brain/awae142
- By:
- Publication type:
- Article
Mitochondrial haplogroups and cognitive progression in Parkinson's disease.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 3, p. 486, doi. 10.1002/ana.26719
- By:
- Publication type:
- Article
Reply to "Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers".
- Published in:
- 2019
- By:
- Publication type:
- letter
Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mendelian randomization of serum urate and parkinson disease progression.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 6, p. 862, doi. 10.1002/ana.24281
- By:
- Publication type:
- Article
Plasma urate concentrations and possible REM sleep behavior disorder.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 12, p. 2368, doi. 10.1002/acn3.50929
- By:
- Publication type:
- Article
Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1522, doi. 10.1002/acn3.671
- By:
- Publication type:
- Article
Red hair, MC1R variants, and risk for Parkinson's disease - a meta-analysis.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 3, p. 212, doi. 10.1002/acn3.381
- By:
- Publication type:
- Article
Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.590573
- By:
- Publication type:
- Article
Postmortem Brain Levels of Urate and Precursors in Parkinson's Disease and Related Disorders.
- Published in:
- Neurodegenerative Diseases, 2013, v. 12, n. 4, p. 189, doi. 10.1159/000346370
- By:
- Publication type:
- Article
Plasma Urate and Progression of Mild Cognitive Impairment.
- Published in:
- Neurodegenerative Diseases, 2008, v. 6, n. 1/2, p. 23, doi. 10.1159/000170883
- By:
- Publication type:
- Article
Enhancement of Diphtheria Toxin Potency by Replacement of the Receptor Binding Domain with Tetanus Toxin C-Fragment.
- Published in:
- Journal of Neurochemistry, 2000, v. 74, n. 6, p. 2528, doi. 10.1046/j.1471-4159.2000.0742528.x
- By:
- Publication type:
- Article
Contrasting Calcium Dependencies of SAPK and ERK Activations by Glutamatein Cultured Striatal Neurons.
- Published in:
- Journal of Neurochemistry, 1999, v. 72, n. 6, p. 2248, doi. 10.1046/j.1471-4159.1999.0722248.x
- By:
- Publication type:
- Article